(146) While data for patients treated with CAR T remains limited, thrombopoietin (TPO) agonists have been given successfully to patients with prolonged or late thrombocytopenia, and have also been noted to improve anemia in some instances. This evidence concerns the gene TPO and Thrombocytopenia.